Latest News

Gregory Lubiniecki, MD
Pembrolizumab/Lenvatinib Regimens Miss Survival End Points in Metastatic NSCLC

September 22nd 2023

The first-line combination of pembrolizumab, lenvatinib, pemetrexed, and platinum-containing chemotherapy did not meet the dual primary end points of overall survival and progression-free survival compared with pembrolizumab plus pemetrexed and platinum-containing chemotherapy in patients with metastatic, nonsquamous non–small cell lung cancer in whom EGFR-, ALK- or ROS1-directed therapies were not indicated.

Enfortumab Vedotin Plus Pembrolizumab Generates Survival Benefit in Previously Untreated Advanced Urothelial Cancer
Enfortumab Vedotin Plus Pembrolizumab Generates Survival Benefit in Previously Untreated Advanced Urothelial Cancer

September 22nd 2023

Perioperative Nivolumab Plus Chemotherapy in NSCLC | Image   Credit: © anusorn - stock.adobe.com
Perioperative Nivolumab Plus Chemotherapy Improves EFS in Resectable NSCLC

September 22nd 2023

Florian Lordick, MD
Tislelizumab Approved in Europe for Advanced ESCC After Platinum-Based Chemotherapy

September 19th 2023

Lung cancer: © - stock.adobe.com
Adjuvant Pembrolizumab Receives Positive CHMP Opinion for High-Risk NSCLC After Resection and Chemo

September 15th 2023

Video Series
Video Interviews
Podcasts
Latest CME Events & Activities

25th Annual International Lung Cancer Congress®

Register Now!

Advances In™: Meeting Unmet Clinical Needs in AML with Evolving Therapeutic Approaches

View More

Reflective Case-Based Oncology Collective: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care

View More

Bridging the Care Gap in Anemia in CKD: A Comprehensive Guide to Enhancing Patient Care

Register Now!

Antibody-Drug Conjugates in Gynecological Cancer – Setting the Stage

View More

Community Practice Connections™: Chronic Fibrosing ILDs With Progressive Phenotype–Are You Aware of the Latest Data on Diagnosis and Emerging Treatments?

View More

Catching Them Early: A Real-World Case Discussion on the Application of Testing Methodologies to Identify Key Markers Across NSCLC

View More

Shaping the Management of Multiple Sclerosis – The Potential for BTK Inhibitors in Clinical Practice

View More

Anemia of Chronic Kidney Disease: Improving Recognition and Early Treatment in the Primary Care Setting

View More

Transforming Multiple Sclerosis Care – Clinical Updates on the Effects of BTK Inhibitors

10/13/2023

Register Now!

20th Annual Meeting of the International Society of Gastrointestinal Oncology®

Register Now!

Advances In™ Pediatric Neuroblastoma: Exploring Current and Emerging Therapeutic Approaches for Relapsed/Refractory Disease and CNS Metastases

View More

Medical Crossfire®: Diagnostic and Clinical Considerations in Cutaneous T-Cell Lymphoma for the Dermatologist and the Collaborative Cancer Team

View More

Clinical Consultations: Individualizing Management of Uveitic Macular Edema - Clinical Updates in Treatment Options

View More

From Clinical Trials to Clinical Practice – Incorporating Screening and Assessment Strategies for the Early Diagnosis of Alzheimer Disease

View More

5th Annual Precision Medicine Symposium: An Illustrated Tumor Board

Register Now!

Taking Pompe Disease Management to the Next Level: Optimizing Clinical Assessments and Treatment Decision-Making

View More

Evaluating the Evolution of CKD Treatment: What’s New and How Can We Incorporate It?

View More

2022 BURST Year in Review™: Reflecting on Recent Evidence for Testing in Patients with GI Cancers

View More

2nd Annual International Congress on Pediatric Oncology

View More

2022 BURST Year in Review™: How Has Recent Evidence in Testing Elevated Outcomes in Patients with Lung Cancers

View More

4th Annual Virtual Tumor Board®: Diagnosis and Management of Polycythemia Vera and Myelofibrosis

View More

Burst CME: Regulatory Approval Pathways for Influenza Vaccines

View More

Medical Crossfire®: Experts Address Your Burning Questions on the Evolving Treatment of MF, PV, and ET!

View More

Burst CME: Selecting an Appropriate Influenza Vaccine for Adults 65 Years and Older

View More

Expanding Options Beyond Conventional Therapy in HR+ Breast Cancer to Overcome Unmet Needs

View More

Community Practice Connections™: 23rd Annual International Lung Cancer Congress®

View More

21st Annual School of Breast Oncology

Register Now!

Oncology Consultations®: Leveraging Clinical Data and Trials to Inform Treatment for Patients with PV

View More

41st Annual CFS®: Innovative Cancer Therapy for Tomorrow®

Register Now!

More News